scispace - formally typeset
F

Feng Zhang

Researcher at Fudan University

Publications -  2715
Citations -  225233

Feng Zhang is an academic researcher from Fudan University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 172, co-authored 1278 publications receiving 181865 citations. Previous affiliations of Feng Zhang include Cincinnati Children's Hospital Medical Center & Nanjing Medical University.

Papers
More filters
Journal ArticleDOI

Application of gibberellic acid to the surface of soybean seed (t Glycine max (L.) Merr.) and symbiotic nodulation, plant development, final grain and protein yield under short season conditions

Feng Zhang, +3 more
- 01 Jan 1997 - 
TL;DR: The results indicated that GA3 application accelerated seedling emergence but decreased plant nodulation and nitrogen accumulation at early plant growth stages, however, these initial negative effects were overcome as the plants developed.
Patent

Silane modified polyether sealant with excellent water soaking bonding performance and preparation method thereof

Zhao Rui, +4 more
TL;DR: In this paper, a silane modified polyether sealant with excellent water soaking bonding performance and a preparation method was described, which relates to the field of a Silane Modified Polyether Sealant.
Journal ArticleDOI

Integration of transcriptome-wide association study and messenger RNA expression profile to identify genes associated with osteoarthritis.

Xin Qi, +10 more
- 06 Mar 2020 - 
TL;DR: A group of OA-associated genes and pathways are identified, providing novel clues for understanding the genetic mechanism of Oa.
Patent

CPF1 complexes with reduced indel activity

Feng Zhang, +4 more
TL;DR: In this article, the authors present a DNA-targeting CRISPR effector protein and at least one targeting nucleic acid component, like a guide RNA, which is used to guide RNA.
Journal ArticleDOI

iTreg induced from CD39+ naive T cells demonstrate enhanced proliferate and suppressive ability

Yunjie Lu, +8 more
- 01 Oct 2015 - 
TL;DR: It is demonstrated that CD39(+) iTreg cells acquire high suppressive capacity in vitro and vivo, and this may provide a new insight into Treg cell therapy in GVHD clinical trials.